-
1
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Published 2020“…American Society of Hematology…”
Journal article -
2
Elucidation of the EP defect in Diamond-Blackfan anemia by characterization and prospective isolation of human EPs.
Published 2015“…American Society of Hematology…”
Journal article -
3
Repressed chromatin drives leukaemogenesis in mutant IDH2 acute myeloid leukaemia via inhibition of granulocyte differentiation and cell cycle progression
Published 2021“…American Society of Hematology…”
Conference item -
4
Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up
Published 2020“…American Society of Hematology…”
Journal article -
5
A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acut...
Published 2021“…American Society of Hematology…”
Conference item -
6
Systemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for...
Published 2001“…American Society of Hematology…”
Journal article -
7
Expression of the human alpha-globin cluster in the absence of the major regulatory element Mcs-R2
Published 2018“…American Society of Hematology…”
Conference item -
8
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis
Published 2020“…American Society of Hematology…”
Journal article -
9
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis
Published 2023“…American Society of Hematology…”
Journal article -
10
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Published 2017“…American Society of Hematology…”
Journal article -
11
A critical epithelial survival axis regulated by MCL-1 maintains thymic function in mice
Published 2017“…American Society of Hematology…”
Journal article -
12
Degrading JAK2 in ALL by ruxolitinib-based PROTACs
Published 2021“…American Society of Hematology…”
Journal article -
13
Outcomes for patients with late-stage mutant-IDH2 (m IDH2) relapsed/refractory acute myeloid leukemia (R/R AML) treated with enasidenib vs other lower-intensity therapies in the ra...
Published 2021“…American Society of Hematology…”
Conference item -
14
Characterization of factors determining the kinetics of disease relapse after allogeneic Stem Cell Transplantation (allo-SCT) or chemotherapeutic consolidation for Acute Myeloid Le...
Published 2016“…American Society of Hematology…”
Conference item -
15
Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
Published 2020“…American Society of Hematology…”
Journal article -
16
Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes.
Published 2014“…American Society of Hematology…”
Journal article -
17
A remarkable case of HbH disease illustrates the relative contributions of the α-globin enhancers to gene expression
Published 2021“…American Society of Hematology…”
Journal article -
18
Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia
Published 2020“…American Society of Hematology…”
Journal article -
19
Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: results from the NCRI AML trials
Published 2018“…American Society of Hematology…”
Conference item -
20
Epistasis between the haptoglobin common variant and α+thalassemia influences risk of severe malaria in Kenyan children
Published 2014“…American Society of Hematology…”
Journal article